30Jan 2024
Endogenous Erythropoietin Levels and Clinical Outcomes in TAVI Patients

Endogenous Erythropoietin Levels and Clinical Outcomes in TAVI Patients

A study involving 263 patients demonstrated that high baseline levels of endogenous erythropoietin (EPO) in patients undergoing trans-catheter aortic valve implantation (TAVI) are independently linked to increased mortality and morbidity. The high EPO group exhibited advanced anemia, renal impairment, and hypoalbuminemia, leading to a significantly higher cumulative incidence of adverse outcomes compared to lower EPO groups. The study suggests an independent association between elevated baseline EPO levels and mortality/morbidity post-TAVI, raising questions about the potential benefits of aggressive intervention on elevated EPO levels in this patient cohort.

  • #cardiology

Like

Save

Share